Financial News

Can Vertex Keep Climbing?

Vertex Pharmaceuticals (VRTX) has had a great week. The drug maker released stellar late-stage clinical trial data late Tuesday for its new cystic fibrosis drug, and its share price has surged more than 20% in response. Is it too late to buy? Maxim Group analyst Jason McCarthy sees Vertex climbing another 34% in the next […]
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Feedback